Abstract. Genetic, biochemical, and structural data support a model in which axonemal radial spokes regulate dynein-driven microtubule sliding in Chlamydomonas flagella. However, the molecular mechanism by which dynein activity is regulated is unknown. We describe results from three different in vitro approaches to test the hypothesis that an axonemal protein kinase inhibits dynein in spoke-deficient axonemes from Chlamydomonas flagella. First, the velocity of dynein-driven microtubule sliding in spokedeficient mutants (pfl4, pfl7) was increased to wildtype level after treatment with the kinase-inhibitors HA-1004 or H-7 or by the specific peptide inhibitors of cAMP-dependent protein kinase (cAPK) PKI(6-22)amide or N~-acetyl-PKI(6-22)amide. In particular, the peptide inhibitors of cAPK were very potent, stimulating half-maximal velocity at 12-15 nM. In contrast, kinase inhibitors did not affect microtubule sliding in axonemes from wild-type cells. PKI treatment of axonemes from a double mutant missing both the radial spokes and the outer row of dynein arms (pf14pf28) also increased microtubule sliding to control (pf28) velocity. Second, addition of the type-II regulatory subunit of cAPK (RII) to spoke-deficient axonemes increased microtubule sliding to wild-type velocity. Addition of 10 #M cAMP to spokeless axonemes, reconstituted with RU, reversed the effect of RII. Third, our previous studies revealed that inner dynein arms from the Chlamydomonas mutants pf28 or pf14pf28 could be extracted in high salt buffer and subsequently reconstituted onto extracted axonemes restoring original microtubule sliding activity. Inner arm dyneins isolated from PKI-treated axonemes (mutam strain pf14pf28) generated fast microtubule sliding velocities when reconstituted onto both PKItreated or control axonemes. In contrast, dynein from control axonemes generated slow microtubule sliding velocities on either PKI-treated or control axonemes. Together, the data indicate that an endogenous axonemal cAPK-type protein kinase inhibits dynein-driven microtubule sliding in spoke-deficient axonemes. The kinase is likely to reside in close association with its substrate(s), and the substrate targets are not exclusively localized to the central pair, radial spokes, dynein regulatory complex, or outer dynein arms. The results are consistent with a model in which the radial spokes regulate dynein activity through suppression of a cAMP-mediated mechanism.
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YNEINS are a family of microtubule-based mechanoenzymes responsible for eukaryotic ciliary and flagellar motility, as well as for certain forms of cytoplasmic transport (Gibbons, 1989) . Although much is known about the composition and structural organization of dyneins in flagellar axonemes (Witman, 1992) , little is known about the coordinated regulation of dynein-driven microtubule sliding that produces regular bending of flagella (see Brokaw, 1994) .
Genetic and. biochemical approaches using Chlamydomonas have revealed a functional interaction between the radial spokes/central pair apparatus and the dynein arms that is likely part of a mechanism that controls microtubule sliding. For example, mutations that result in disrupted assembly of the radial spokes or the central pair apparatus also result in flagellar paralysis (reviewed in Huang, 1986; Curry and Rosenbaum, 1993) . However, extragenic suppressor mutations that rescue oscillatory beating without restoration of the radial spokes or the central pair have been recovered Brokaw et al., 1982; Piperno et al., 1992 Piperno et al., , 1994 Porter et al., 1992 Porter et al., , 1994 . These results revealed that the radial spokes and central pair have regulatory functions in tlagellar beating that can be bypassed by other components in the axoneme. The molecular mechanism(s) by which the radial spokes and central pair regulate dynein is unknown. However, in each case studied so far, mutations that suppress paralysis, because of disrupted central pair or spoke components, have defects in either the outer or inner dynein arms Brokaw and Kamiya, 1987; Luck and Piperno, 1989; Porter et al., 1992 Porter et al., , 1994 or in a complex of proteins referred to as the dynein regulatory complex (drc) ~ Piperno et al., 1992 Piperno et al., , 1994 , thought to be located at the junction between the inner row of dynein arms and the radial spokes (Mastronarde et al., 1992; Piperno et al., 1992 Piperno et al., , 1994 . Thus, one hypothesis is that the radial spokes, in conjunction with the central apparatus and drc, serve to regulate flagellar function by local activation of dynein-driven microtubule sliding. This hypothesis was tested by the analysis of microtubule sliding velocity in isolated axonemes from mutant strains of Chlamydomonas missing radial spoke components (Smith and Sale, 1992b) . It was discovered that in spoke-deficient mutants the velocity of dynein-driven microtubule sliding was significanOy reduced compared to wild-type controls. Furthermore, using a precise reconstitution assay and focusing on just the inner row of dynein arms, it was found that dynein extracted from spokeless axonemes gained the ability to translocate microtubules at wild-type velocities upon reconstitution with axonemes containing intact spokes. Moreover, when dynein derived from axonemes possessing wild-type spokes was reconstituted with axonemes missing spokes, the dynein retained the ability to generate rapid microtubule sliding velocity in the absence of spokes (Smith and Sale, 1992b) . These results indicate that the radial spokes activate dynein-driven microtubule sliding. Furthermore, the results suggest that dynein is activated by a posttranslational modification, possibly phosphorylation or dephosphorylation. The hypothesis that phosphorylation regulates dynein activity in Chlamydomonas flagella is consistent with the results of Hasegawa et al. (1987) , who reported that inhibition of cAMP-dependent protein kinase (cAPK) increased the percentage of wild-type axonemes that reactivate in vitro. The mechanism through which cAPK affects reactivation is unknown.
To test the hypothesis that phosphorylation regulates microtubule sliding, we used protein kinase inhibitors and a reconstitution approach combined with in vitro assay of dynein-driven microtubule sliding in spoke-deficient axonemes. We found that inhibitors of cAPK significantly increased the velocity of microtubule sliding in spoke-deficient axonemes, mimicking the effect of radial spokes in previous experiments (Smith and Sale, 1992b) . Similar treatments had no effect on microtubule sliding in axonemes containing wild-type spokes. Likewise, reconstitution of spoke-deficient axonemes with the regulatory subunit of type II cAPK (RID increased microtubule sliding to wild-type control levels. Finally, when inner arm dyneins were extracted from spokedeficient axonemes, which were first treated with a specific cAPK inhibitor and then reconstituted onto either control or inhibitor-treated axonemes depleted of dynein, the dynein restored wild-type microtubule sliding velocity to spokeless 1. Abbreviatior~s used in this paper: cAPK, cAMP-dependent protein kinase; drc, dynein regulatory complex; HA-1004, N-(2-guanidinoethyl)-5-isoquinolinesulfonamide hydrochloride; NAcPKI, N~-acetyl-PKI(6-22) -amide; PKI, amino acid residues 6-22 of the o~ isoform of the heat-stable inhibitor protein of cAPK axonemes. We conclude that in Chlamydomonas, the radial spokes activate dynein-driven microtubule sliding by inhibiting or overriding a cAPK, and that this axonemal protein kinase is not exclusively located in the central pair apparatus, radial spokes, drc, or outer dynein arms.
Materials and Methods

Cell Strains and Growth Conditions
Chlamydomonas reinhardtii strains used were pfl4 (radial spoke deficient; Piperno et al., 1977; Witman et al., 1978) , pfl7 (radial spoke head deficient; Huang et al., 1981) , pf14pf28 (racial spokeless/outer dynein armless; Piperno et al., 1990) , and 137c (wild type). The phenotype of each cell type was verified by electron microscopy. With the exception of pf14pf28, all cells were grown in liquid modified Medium I of Sager and Granick (1953) with aeration over a 14 1~/10 h light/dark cycle (Witman, 1986) . Because of an inability of the pf14pf28 cells to grow flagella in liquid culture, these cells were grown on modified Medium I agar plates at 22°C during a 14 h/ 10 h light/dark cycle for 5-7 d. On the morning of an experiment, pf14/~8 cells were gently scraped and resuspended into 10 mM sodium Hepes, pH 7.4 (10 ml/plate), and the cell suspension was stirred in the light for 1 h.
This treatment induced pf14pf28 cells to grow half-length flagella (5-7/~m) .
Reagents and Kinase lnhibitors
N-(2-guanidinoethyl)-5-isoqulnolinesulfonamide hydrochloride (HA-1004) (Research Biomedicals International, Natick, MA) was made as a 10 mM stock solution in water and stored at -20°C. The regulatory subunit (RID of bovine cardiac type II cAPK (Promega, Madison, WI) was stored as a 1.2 mg/ml solution in Tris-buffered saline at -70°C. PKI(6-22)amide and N~-acetyl-PKI(6-22)amide (referred to in this paper as PKI and NAcPKI, respectively) are peptides with the sequence Thr-Tyr-Ala-Asp-Phe-Ile-AlaSer-Gly-Arg-Thr-Gly-A_rg-Arg-Aan-Ala-Ile-NH2 that correspond to residues 6-22 of the c~ isoform of the heat-stable inhibitor protein of cAPK Walsh and Glass, 1991) . Both of these peptides inhibit cAPK with Ki = 1.6-2.5 nM ) and a high degree of specificity (Glass et al., 1986) . PKI (200/LM stock) and NAcPKI (100/~M stock) were stored at -70oc as trifluoroacetic acid salts in water, and I mM trifluoroacetic acid alone served as a control stock solution. As a control for PKI and NAcPKI, the analogue peptide Na-acetyl-(AlalS.lS,l~)PKI(6 -22)amide (triAlaPKI), in which aianines are substituted for the three required arginines in the PKI sequence, was used. TriAIaPKI is virtually inactive as an inhibitor of cAPK when used at submicromolar concentrations, with a Kt >125/~M (Glass, D., unpublished results) . TriAlaPKI (100/~M stock) was stored in a solution of 4 raM NH~CO3 at 4°C. PKI, NAcPKI, and TriAlaPKI were synthesized as COOH-terminal amides at the Emory University Microchemical Facility, purified by semipreparative reversephase HPLC, and characterized by analytical HPLC, UV spectroscopy, and amino analysis by methods previously described (Glass et ai., 1989; Katz et al., 1989) . The addition of 4 mM NI-Ld-ICO3 to stock solutions of NAcPKI did not alter the observed effects of NAcPKI. Except as noted, all other chemicals were from Sigma Chemical Co. (St. Louis, MO), and deionized water was used throughout.
Isolation of Axonemes and Treatment with Kinase lnhibitors
Flagella were isolated as described previously (Witraan, 1986; Smith and Sale, 1992a) and resuspended in buffer A (10 mM Hepes, 5 mM MgSO4, 1 mM DTT, 0.5 mM ED'rA, 30 mM NaCI, 0.1 mM PMSF, and 0.6 TIU Aprotinin, pH 7.4). The protein concentration of the flagellar suspension was measured with the Bin Pad Laboratories (Richmond, CA) Bradford assay (Bradford, 1976) and adjusted to 0.85 mg/ml. Flagella were demembrahated with 0.5% Nonidet P-40 (Calbiocbem-Novabiocbem Corp., La Jolla, CA), and the axonemes were pelleted at 37,000 g (18,000 rpm) (SS-34 rotor; Sorval], Wilmington, DE) for 20 rain. For all experiments except extraction and reconstitution experiments (see below), the pelleted axonemes were resuspended to their previous volume in buffer B (10 mM Hepes, 5 mM MgSO4, 1 mM DTT, 1 mM EGTA, 50 mM K-acetate, 0.1 mM PMSF, 0.6 TIU Aprotinin, and 0.5% polyethylene glycol). In most experiments, protein kinase inhibitors or their respective carrier, control solutions were added and incubated for 15 rain on ice, and 1 mM ATP (Boehringer Marmhelm Corp., Indianapolis, IN) was added to both inhibitor-treated and control axonemes and incubated for 10 rain at room temperature. The axonemes were then used in micrombule-sliding assays.
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Assay of Microtubule Sliding Velocity ~ 1~
The measurement of the velocity of sliding between doublet microtubules 2" was based on the methods of Oka~ki and Kamiya (1986) and Smith and "~ 14 Sale (1992a,b) with the following modifications. Neither flagella nor axoo nemes were somcated before sliding assays. Axonemes were applied to > 10-15-/d perfusion chambers (see Smith and Sale, 1992a) , and nonadherent .~ 12 axonemes were washed away with ~5 vol ('~75/d) of buffer B minus protease inhibitors (buffer B-PI) with 1 mM ATP. To initiate microtnhule slid-10 ing, buffer B-PI with 1 mM ATP and 2/~g/ml Nngarse (type XXVII protease; Sigma Chemical Co.) (motility buffer) was added by perfusion, s Except where noted, protein kinase inhibitors or their controls were main-0 rained in both the wash and motility buffers. Microtubule sliding was observed by dark-field microscopy and recorded by a silicon-intensified target camera (66 SIT or VE-1000 SIT; Dage-MTI, Inc., Michigan City, IN) omo videotape by a videocasseoe recorder equipped with a jog/shuttle device for 20. field by field analysis (AG-1960 or AG-1970 Panasonic, Secancus, NJ) .
Analysis of the velocity of microtubule sfiding was from videotapes and
18.
measurements were made manually from calibrated videoscreens at a final magnification of 3,200 using the jog/shuttle to measure displacemem versus time. To ensure reproducibility, the following procedures were adopted. ~ 16 First, only sliding events that were unequivocally occurring between a singie pair of micmtubuie doublets were measured (Okngaki and Kamiya, "=.~ 14 1986). Sliding events that occur simultaneously between two or more pairs "~ o of microtubnie doublets produce apparent velocities that are faster than individual events but are not a simple sum of the multiple events. Second, to > 12 eliminate bias, every measurable sliding event within a field was measuwA.
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To further reduce possible bias, measurements were repeated by a second observer and experiments were coded for blind measurement. Third, as 10 demonstrated previously Smith and Sale, 1992b) , the composition of the wash and motility buffers have pronounced s effects on the velocity of microtubnie sliding. All of the experiments o reported here were performed using buffer B containing no added calcium (nominally <10 -9 M Ca++). In the presence of kinase inhibitors, increased Ca ++ had a significant effect on microtubule sliding velocity (data not shown). All data are presented as means + standard error of the mean. The Student's t test (0.05 level) was used to determine significant differences be- [weerl lneans. Using these procedures, the mean sliding velocities (see Fig. 2 b) are faster than those we reported previously (cf. Smith and Sale, 1992b ), but they show the same relative difference between speke-contaimng and spokedeficient axonemes. The mean microtnhuie sliding velocity of wild-type axonemes (137c) found with this assay (21/~m/s) correlates well with that calculated from live beating flagella by Brokaw and Luck (1985) .
Extraction and Recombination of Inner Arm Dyneins
Flagella were isolated from pfi4pf28 cells as described above. The flagellar protein concentration was adjusted to 0. 35 rag/m l, and 0. 5 % (wt/vol) NP-40 was added to remove the flngellar membrane. Axonemes were pelleted at 11,000 rpm for 12 rain (SSo34 rotor; Sorvnil Instruments, Wilmington, DE) and resuspended in buffer A to half their original volume. This axonemal suspension was divided into two equal aliquots, and 100 nM PIG was added to one aliquot while the other aliquot served as the buffer control. Axonemes were then incubated for 15 rain on ice. ATP (1 raM) was added to both samples, and axonemes were incubated for 10 min at 22°C. Axonemes were concentrated by centrifugation as above and resuspension to 1/10 the original volume ('~3 mg/mi) in buffer A with 1 mM ATP + 100 nM PIG accordingly. An equal volume of both treated and untreated axonemes were removed and used in the microtubule-sliding assay to measure the velocity of"unextracted axonemes7 Dyneins were then extracted from both remaining axunemal aliquols by elevating the NaC1 concentration to 0.6 M via the addition of 4 M NaCI in buffer A and incubating 15 rain on ice. After pelleting the axonemes as described, the dynein-containing supernatants were collected and dialyzed (molecular mass cutoff = I2,000-14,000 D) twice against 500 mi of buffer A for 30 rain at 4°C. The extracted axonemal pellets were resuspended in barfer A. The two types of inner ann dynein extracts (PIG-treated and control) were recombined 3:1 (vollvol) with each of the :,<X ~x.
pfl4 pfl7
• ~ io l's ~o ~5 ~o HA-1004 (t~M) Figure/. Effects of HA-1004 on the velocity of microtubule sliding in isolated axonemes. (a) Isolated axonemes from pfl4 (missing radial spokes) or pfl7 (missing radial spoke heads) were treated with 15/tM HA-1004 for 15 rain, followed by 1 mM ATP for 10 rain. The sliding velocities in bothpfl4 and pfl7 were significantly increased by HA-1004 (P < 0.001, Student's t test). The data from three (pfl4) or two (pfl7) independent experiments were pooled and are presented as means + standard errors of the mean. The total number of axonemes measured for each mean is shown in parentheses. (b) Isolated pfl7 axonemes were treated with varying concentrations of HA-1004 as described in Materials and Methods. Each point represents >t20 measurements.
two types of extracted axonemes (PiG-treated and control) resulting in all combinations of dynein and axonemes (see Smith and Sale, 1992b) . ARer incubating for 15 rain at room temperature, the velocity of micrombule sliding was measured for each combination and for PiG-treated and control extracted axonemes without added inner arms.
Results
Protein Kinase Inhibitors Increase the Velocity of Microtubule Sliding in Spoke-defective Axonemes
To test the model that the radial spokes regulate dynein through phosphorylation and dephosphorylation, we began testing the effects of specific and potent inhibitors of protein kinases on in vitro microtubule sliding. As described previously (Smith and Sale, 1992b) , dynein in axonemes deficient for either the entire radial spoke (pfl4) or the spoke head and pfl7 replotted after normalization to the maximum mean sliding velocity for each experiment. The difference between the absolute velocities ofpfl4 and pfl7 axonemes is caused by variation in the baseline values of these two experiments. When directly compared over a series of experiments, there is little difference in sliding velocity between axonemes from pfl4 and pfl7 (see (pfl7) translocated microtubules at 50-60% of the rate produced by dynein in wild-type axonemes (Fig. 1 a, control, vs. Fig. 2 b, 137c) . Treatment of isolated axonemes with the kinase inhibitor HA-1004 (15/~M), as described in Materials and Methods, significantly increased the velocity of microtubule sliding in spoke-deficient mutants (Fig. 1 a) . In contrast, similar treatment of axonemes from wild-type cells had no effect on microtubule sliding velocity (not shown). The finding that microtubule sliding velocity in bothpfl4 and pfl7 axonemes is stimulated by HA-1004 indicates that this effect is not specific to a particular mutation. Also, the ability of kinase inhibitors to increase microtubule sliding when applied to isolated axonemes indicates that their target(s) is tightly associated with axonemes. The effect of HA-1004 on sliding velocity in spokedeficient axonemes is dose dependent with half maximal activation of microtubule sliding velocity occurring at 1-5 #M (Fig. I b) . The kinase inhibitor H-7 also increases sliding velocity in spoke-deficient but not spoke-containing axonemes (data not shown). Together these results suggest that an endogenous cyclic nucleotide-dependent protein kinase inhibits dynein-induced microtubule sliding in spoke-deficient axonemes. To further test this model, we examined the effect of specific and potent peptide inhibitors of protein kinases.
An Endogenous cAMP-dependent Protein Kinase Inhibits Dynein Activity in Spoke-defective Axonemes
Some of the most potent and specific protein kinase inhibitors are PKI peptides derived from the heat-stable inhibitor protein of cAPK. Unlike HA-1004 and H-7, which interact with the ATP-binding sites of protein kinases (Hidaka et al., 1984; Hagiwara, et al., 1987) , PKI potently inhibits cAPK by acting as a pseudosubstrate and binding to the active site (Walsh and Glass, 1991) . However, like the H-compounds, 100 nM PKI or 100 nM NAcPKI significantly increased the microtubule sliding velocity ofpfl7 axonemes (Fig. 2 a) . In contrast, the control peptide triAlaPKI did not affect microtubule sliding in spoke-deficient axonemes (Fig. 2 a) . There was no detectable difference between the effieacies of PKI and NAcPKI, and similar results were found for axonemes from pfl4 (not shown) and the double mutant pf14pf28 (see below).
PKI and NAcPKI both stimulated microtubule sliding velocity in a dose-dependent manner. The data from one experiment with pfl4 and one with pJ17 is shown in Fig. 2 b. The effects of PKI peptides on pfl4 and pfl7 were very similar, as can be seen when the data in Fig. 2 bare normalized to the maximal sliding velocity (Fig. 2 b, inset) .
Half-maximal activation of microtubule sliding velocity was achieved with 12 nM and 15 nM PKI for py14 and pfl7, respectively, for these standardized conditions. These concentrations are consistent with a specific inhibition of cAPK and 3,000-fold lower than the K~ for the closely related cGMP-dependent protein kinase (Glass et al., 1986 (Glass et al., , 1992 . In contrast, throughout the same concentration range, PKI did not affect the already rapid microtubule sliding velocity in wild-type 137c axonemes (Fig. 2 b) . Furthermore, the effect of the peptide inhibitor appeared to be rapid in that very short incubation with 100 nM PKI ('~0.5 min, in motility buffer only) resulted in activation of microtubule sliding velocity similar to that found with 25-min preincubations Figure 3 . PKI rapidly affects microtubule sliding velocity in spokedeficient axonemes. Isolated pfl4 axonemes were treated with buffer (-); 100 nM PKI only in the motility buffer used to induce microtubule sliding, which resulted in ~0.5 min treatment before the occurrence of sliding (0.5 min), or 100 nM PKI for t>25 min. All axonemes were preincubated with 1 mM ATP for >/10 min before induction of microtubule sliding. Both PKI treatments significantly increase the sliding velocity from the control level (P < 0.001), and there was no difference between short and long treatments with PKI (P > 0.35). The means represent pooled results from two separate experiments. The total number of axonemes measured for each mean are shown in the parentheses.
( Fig. 3) . The potent effect of the two inhibitory PKI peptides and the inactivity of the control peptide strongly suggest that PKI elevates microtubule sliding velocity by specifically inhibiting a cAPK bound to Chlamydomonas axonemes.
Regulatory Subunit of cAPK Increases Microtubule Sliding Velocity in Spoke-deficient Axonemes
The finding that cAPK inhibitors increased the velocity of dynein-driven microtubule sliding in isolated axonemes sug- 
Control PKI Figure 5 . Effect of PKI on inner arm dyneins. Isolated axonemes frompf14pf28 (missing radial spokes and outer arm dyneins) were treated with 100 nM PKI. PKI significantly increased the velocity of microtubule sliding in pf14pf28 axonemes (P < 0.001).
gested that a form of cAPK is active and structurally bound to isolated, spoke-deficient axonemes. In all reported cases in higher eukaryotes, cAPK exists as a heteromer of catalytic and regulatory polypeptides (Taylor et al., 1990) . Cyclic AMP stimulates kinase activity by binding to the regulatory subunit and promoting subunit dissociation, thus releasing inhibition of the catalytic subunit. We found that cAMP had no effect on microtubule sliding in isolated axonemes, which would be expected if dissociated, active catalytic subunits were present (Fig. 4) . Therefore, our data suggested that the putative axonemal regulatory subunit was lost during fractionation and purification of axonemes. To further examine the model that cAPK regulates dynein-driven microtubule sliding, we tested whether the addition of exogenous regulatory subunit would inhibit any free catalytic subunit present and increase the velocity of microtubule sliding in spokedeficient axonemes. As predicted, the addition of 200 nM bovine cardiac regulatory subunit type II (RII) significantly increased the velocity of microtubule sliding in pfl4 axonemes; the effect of RII was similar to that of PKI (Fig. 4) . Furthermore, as expected for a cAPK-mediated mechanism, 10 #M cAMP reversed the effect of RII addition (Fig. 4) . As stated, cAMP alone did not affect microtubule sliding (Fig. 4) . These results further support the hypothesis that cAPK inhibits microtubule sliding in spoke-deficient axonemes and suggest that a substantial fraction of the regulatory subunit of cAPK is solubilized during the isolation of axonemes. The results also corroborate the conclusion that the catalytic subunit of the kinase is not soluble, but is built into the axoneme.
Inner Arm Dyneins May Be the Targets of cAPK Regulation
One hypothesis to explain the results described above is that cAPK regulates microtubule sliding velocity by modulating the phosphorylation of a dynein component(s). Alternatively, cAPK may modify some other, nondynein component that affects microtubule sliding velocity. To distinguish between these possibilities and to begin to identify the sub- strates involved in the regulation of microtubule sliding, we used a reconstitution assay similar to that described by Smith and Sale (1992b) . In this previous study, we found that wildtype spokes induced a change in an inner dynein arm component necessary for increased microtubule sliding velocity (see Introduction). One possibility is that wild-type spokes and inhibitors of cAPK effect the same changes. For reconstitution experiments, we focused on only the inner row of dynein arms for reasons previously described (Smith and Sale, 1992a,b) . Therefore, we used the double mutant pf14pf28, which lacks both the radial spokes and the outer arms, to test the ability of the inner arms alone to respond to PKI. Treatment ofpJ14pf28 axonemes with PKI in conditions identical to those used in Fig. 2 ( i.e., buffer B throughout) significantly increased their microtubule sliding velocity (Fig. 5) . Therefore, the inner row of dynein arms is sufficient for regulation by both cAPK and the radial spokes.
To further characterize the involvement of inner arm dyneins in regulation by cAPK, we performed dynein extraction and reconstitution experiments (Fig. 6 ). Axonemes were isolated from pf14pf28 cells, and half were treated with PKI, while half were left as the control. An aliquot was taken from each of these just before salt extraction of the dynein and used in the sliding assay (Fig. 6 , Pre-Extr). As expected, the sliding velocity of PKI-treated axonemes (Fig. 6 , crosshatched bar) was significantly greater than the velocity of control axonemes (Fig. 6, solid bar) . As described in Materials and Methods, inner arm dynein was then extracted from both PKI-treated and control axonemes. The PKI-treated dynein (Fig. 6, diagonally lined bars) was reconstituted onto both extracted PKI-treated (Fig. 6 , PKIAxos) and extracted control (Fig. 6, ConAxos) axonemes. The control dynein (Fig. 6 , horizontally lined bars) was also reconstituted onto both extracted PKI-treated (Fig. 6 , PKIAxos) and extracted control (Fig. 6, ConAxos) axonemes. The PKI-treated dynein (diagonally lined bars) generated fast microtubule sliding velocities on both control (ConAxos) and PKI-treated (PKIAxos) axonemes. In the reciprocal experiments, control dynein (horizontally lined bars) generated only slow microtubule sliding on both control (ConAxos) and PKl-treated axonemes (PKIAxos). Extracted axonemes without re, added dynein (ExAxos) did not exhibit microtubule sliding, indicating that the dynein was functionally extracted (see also, Smith and Sale, 1992a) . These results demonstrated that, as the radial spokes, PKI regulates microtubule sliding by causing a stable change in a component that is extracted from axonemes under conditions typically used to isolate dynein. Furthermore, these results suggest that cAPK inhibits microtubule sliding by phosphorylation of a salt-extractable component(s), which may include a subunit(s) of inner arm dyneins.
Discussion
Chlamydomonas Axonemes Contain a cAMP-dependent Protein Kinase That Regulates Microtubule Sliding
Diverse evidence has indicated a role for cAPK in regulation of ciliary and flagdlar motility (Stephens and Stommel, 1989; Tash, 1989) . For example, initial motility of many sperm flagella requires cAMP (Brokaw, 1987; Lindemann and Kanous, 1989; Morisawa and Okuno, 1982) . The targets and mechanisms of cAMP and cAPK action are largely unknown. However, one hypothesis is that regulation of dynein activity is the ultimate target (Walczak and Nelson, 1994; Barkalow et al., 1994) . The results of this paper indicate that Chlamydomonas flagellar axonemes contain a cAPK that regulates dynein-driven microtubule sliding. In Chlamydomonas, it appears that the protein kinase operates to reduce dynein activity and, as discussed below, may mediate radial spoke regulation of axonemal dynein activity. Furthermore, the results implicate components of the inner row of dynein arms as regulatory substrates for the axonemal kinase. Several lines of evidence with spoke-defigient axonemes support these conclusions. First, inhibitors/of protein kinases increased the velocity of microtubule' sliding with half-maximal activation of sliding occurring at 1-5 #M HA-1004. This concentration is similar to the reported Ki (1-3 /~M) for HA-1004 inhibition of cyclic nucleotide-dependent kinases and lower than the reported/(is for protein kinase C (40 t~M) and myosin light chain kinase (150/zM) (Hidaka et al., 1984) . Second, peptides that are highly specific inhibitors of cAPK increase microtubule sliding velocities to wildtype levels in a dose-dependent manner with the halfmaximal effect occurring at 12-15 riM. The same results were attained using peptides synthesized in two separate batches (not shown). A related control peptide in which the essential arginine residues were replaced with alanines, thereby rendering it inactive as a cAPK inhibitor, did not affect microtubule sliding velocity. Third, the velocity of microtubule sliding was also increased to wild-type levels by the addition of exogenous regulatory subunit of cAPK. Upon addition of exogenous RII, the velocity of microtubule sliding became cAMP dependent. Finally, inner arm dynein extracted from PIG-treated axonemes and reconstituted onto control axonemes retained the ability to translocate microtubules with accelerated velocities.
The results with HA-1004, PIG, and RII strongly suggest that the protein regulating microtubule sliding in spokedeficient axonemes is a form of cAPK. The mechanism by which HA-1004 inhibits cAPK (Hidaka et al., 1984; Hagiwara, et al., 1987) differs from that used by PIG and RII (reviewed in Taylor et al., 1993) . In addition, the sequence in PIG which dictates its high specificity of cAPK binding differs from the sequence in RII that confers specific binding, and these two sequences bind to different domains in cAPK (Taylor et al., 1993) . Because of these differences in mechanisms of binding and action, it is unlikely that all three of these reagents could affect microtubule sliding through a coincidental interaction with any protein other than cAPK. In addition, the finding that cAPK inhibits the velocity of microtubule sliding in Chlamydomonas axonemes is consistent with previous results which indicated that cAMP (Rubin and Filner, 1973; Hartfiel and Amrhein, 1976) or cAPK (Hasegawa et al., 1987) inhibit motility in Chlamydomonas flagella. Our results suggest that cAPK may inhibit motility by inhibiting dynein-driven microtubule sliding.
Because all treatments were performed on isolated axonemes, the kinase is likely to be a structural component of Chlamydomonas axonemes. An alternative explanation is that since the action of cAPK is catalytic, small amounts of contaminating soluble kinase could influence microtubule sliding in vitro. To test this possibility, we compared the microtubule sliding velocities ofpfl7 axonemes prepared by the procedure described in Materials and Methods with axonemes washed three additional times by pelleting and resuspending in fresh buffer. No difference between the two preparations of axonemes was seen in either their baseline or PIG-treated velocities (not shown). This experiment demonstrates that the kinase was not removed by extensive washing, and it suggests that the effects we report were not caused by contaminating soluble enzyme. Similar conclusions were also reached in a recent study of the phosphorylation of the et-heavy chain in the outer dynein arms of Chlamydomonas flagella (King and Witman, 1994) . In addition, the lack of effect of cAMP alone and the ability of exogenous RII to affect microtubule sliding suggest that the catalytic subunit is bound to an axonemal component other than RII. If the catalytic subunit is a structural component of Chlamydomonas axonemes, physical constraints will likely require the kinase to be located within close proximity of its substrates. Since inner arm dyneins are potential targets of phosphorylation, the kinase may be located within or adjacent to the row of inner arms (see below).
Several previous studies have provided evidence that cAPK is associated with the detergent-resistant structures from rat sperm (Horowitz et al., 1984) , ram sperm (San Agustin and Witman, 1994) , and Paramecium (Bonipd and Nelson, 1988; Hamasaki et al., 1989 Hamasaki et al., , 1991 and Tetrahymena (Chilcote and Johnson, 1990) cilia. In rat sperm, the catalytic subunit is probably tethered to the sperm tail via its interaction with the regulatory subunit since cAMP releases most of the catalytic activity from demembranated sperm (Horowitz et al., 1984) . In contrast, catalytic subunit in ram sperm may be bound via interactions with additional proteins. As much as 50% of PIG-sensitive kinase activity remains bound to demembranated ram sperm after treatment with cAMP (San Agustin and Witman, 1994) . Furthermore, a fraction of catalytic subunit in ram sperm is apparently localized to the axoneme (Pariset et al., 1989) , and therefore, the association may be analogous to that in Chlamydomot/as.
Radial Spokes May Affect Microtubule Sliding through the Axonemal cAPK
Our original goal was to elucidate the mechanism by which the radial spokes regulate dynein activity. In spoke-deficient axonemes, protein kinase inhibitors mimic the radial spokes in their ability to increase the velocity of dynein-driven microtubule sliding. In contrast, kinase inhibitors do not affect microtubule sliding in wild-type axonemes that have fast microtubule sliding velocities, even without the addition of kinase inhibitors. These findings support models in which the spokes regulate dynein activity by inactivating cAPK, activating a phosphoprotein phosphatase, or in which the spokes otherwise bypass the inhibitory effects of phosphorylation. In any case, the spokes would function to prevent the kinase from inhibiting motility and maintain permissive conditions for maximal dynein-driven microtubule sliding. At this point, we cannot rule out the possibility that the effects of kinase inhibitors and radial spokes may be coincidental. However, because the velocity of microtubule sliding in axonemes with wild-type radial spokes is insensitive to kinase inhibitors, the spokes at least are capable of bypassing the effects of the protein kinase on microtubule sliding. Measuring parameters of flagellar motility other than microtubule sliding velocity may reveal more information about the role of cAPK in wild-type axonemes.
As outlined in the Introduction, the radial spokes are thought to regulate flagellar beating through a mechanism that involves the central pair apparatus and the drc Piperno et al., 1992 Piperno et al., , 1994 . Mutations in the spokes and central pair lead to flagellar paralysis (Huang, 1986) , and secondary mutations in the dynein arms or drc suppress this paralysis (Piperno et al., 1992 (Piperno et al., , 1994 Porter et al., 1992 Porter et al., , 1994 . If cAPK activity is involved in this pathway, axonemes that are paralyzed because of mutations in the central pair might be expected to respond to protein kinase inhibitors in the way that spoke-mutant axonemes do. Our recent experiments with the paralyzed, central pairless mutant pfl8 support the hypothesis that inhibition of dyneindriven microtubule sliding by cAPK may be fundamental to paralysis. The velocity of microtubule sliding in pfl8 (13.1 + 1.10 #m/s, n =25) is similar to that inpfl4 andpfl7 (e.g., Fig. 2 ) and significantly increased to wild-type levels by 100 nM PIG (21.7 + 1.20 #m/s, n = 25; Habermacher, G., unpublished results). The finding that kinase inhibitors activate microtubule sliding in both radial spoke and central pair mutants raises the possibility that certain suppressor mutations may restore beating to paralyzed flagella by inactivating the kinase or altering its substrate. However, in preliminary experiments, we were unable to reactivate in vitro beating ofpfl7 axonemes with PKI. Although a negative result in this experiment provides little information, it may suggest that genetic restoration of beating by the suppressor mutations involves additional changes in the flagellar machinery.
To study the regulation of dynein-driven microtubule sliding, we have chosen to assay the sliding velocity of microtubule doublets in protease-treated axonemes (Okagaki and Kamiya, 1986; Smith and Sale, 1992a) . This method has several advantages. First, the translocation of microtubules by dynein is uncoupled from bend generation; therefore, sliding velocity should reflect the motor activity of dynein in the axoneme. Second, dynein activity can be assessed in otherwise paralyzed axonemes (e.g., spoke-defective axonemes). Most importantly, since dynein activity is assayed in situ (i.e., in the axoneme), interactions between dyneins and other axonemal components are maintained and can be studied independent of membrane and cytoplasmic matrix fractions. These advantages were crucial in allowing us to identify the involvement of cAPK and the radial spokes in regulating dynein-driven microtubule sliding. However, the microtubule sliding assay has certain limitations. The extent of proteolysis and the identity of the polypeptides affected are not fully understood. Be that as it may, the sliding assay reproducibly detects changes in the velocity of microtubule sliding that are induced by both the radial spokes and protein kinase inhibitors. Therefore, the sliding assay provides information on at least these aspects of the regulation of flagellar motility. Another disadvantage of the sliding assay is that we do not know which specific microtubule doublets are undergoing sliding at any instant. In many cases, we can measure the sliding velocity of several individual doublets from one axoneme, and different doublets within one axoneme slide at similar velocities. This finding suggests that most or all doublets are active and under similar regulatory controls. However, we cannot eliminate the possibility that select subsets of microtubule doublets are sliding in the conditions used.
Inner Arm Dyneins May contain a Substrate for cAPK
A variety of evidence has indicated that dynein from several axonemal sources may contain cAPK substrates involved in regulation of motility. For example, in Paramecium, increased cAMP results in faster swimming speed and increased ciliary beat frequency (Bonini and Nelson, 1988; Hamasaki et al., 1989) . Experiments that measured the translocation of microtubules by purified dynein adsorbed to glass support the idea that cAMP-dependent phosphorylation of a 29-kD polypeptide in Paramecium outer arm dynein is involved in the regulation of beat frequency (Hamasaki et al., 1991; Barkalow et al., 1994) . In mussel gill cilia, cAMPdependent phosphorylation of presumptive 21-and 27-kD outer arm dynein light chains (Stephens and Prior, 1992) correlates with cAPK activation of motility in vitro (Stephens and Stommel, 1989) . Tetrahymena outer arm dynein is phosphorylated on 78-, 37-, 34-, and 30-kD polypeptides by an axonemal cAPK, but this is not correlated with a change in motility (Chilcote and Johnson, 1990) . In addition, Chlamydomonas outer and inner arm dyaeins contain substrates for an axonemal kinase in vivo and in vitro Piperno et al., 1981; King and Witman, 1994) .
Our inner arm dynein extraction and re, constitution experiments implicate a component of Chlamydomonas inner arm dyneins as one of the substrates for cAPK. Inner arm dynein extracted from PKI-treated axonemes supported fast sliding velocities on both PKI-treated and control-treated extracted axonemes. In other words, the velocity of microtubule sliding was determined by the source of the dynein extract, and the source of the axonemes was irrelevant. A simple explanation for this result is that PKI changes the phosphorylation level of at least one of the polypeptides that are extracted by high salt, and this altered polypeptide(s) dictates accelerated sliding velocities even on control axonemes. An alternative explanation is that PKI contaminates the dynein extracts. However, this latter explanation is unlikely because PKI is able to freely diffuse through the dialysis membrane used to desalt extracts. Therefore, the concentration of PKI in the dialyzed extracts should be less than that required to increase microtubule sliding.
Because inner arm dyneins actually perform the work of microtubule translocation in pf14pf28, inner arm dynein subunits are attractive candidates as regulatory substrates. However, numerous salt-extractable, axonemal polypeptides are phosphorylated in vivo King and Witman, 1994) and in vitro (King and Witman, 1994 ; Howard, D., unpublished observations) and are candidate substrates. Our results suggest two restrictions on candidate substrates involved in the regulation of motility. First, because PKI-treated axonemes reconstituted with control dynein extracts had slow microtubule sliding velocities that were indistinguishable from control axonemes with control dynein, the target of kinase regulation must be extracted from axonemes. This restriction makes the drc, which is resistant to salt extraction (Piperno et al., 1994) , a poor candidate substrate. Second, because the PKI-treated dynein extract conferred fast sliding velocities to control axonemes, the target of the kinase must retain its function and regulated state when reassociated with axonemes. Inner arm dyneins are extracted from outer armless mutants to >90% (Smith and Sale, 1992a ; Howard, D., unpublished observations).
Furthermore, Chlamydomonas inner arm dyneins rebind to their original positions in vitro and restore function (Smith and Sale, 1992a,b) , and as mentioned, inner arm dyneins contain phosphorylation substrates. Therefore, inner arm dyneins meet the criteria for a regulatory kinase substrate, but it is impossible to rule out other proteins in the extract as substrates involved in the regulation of microtubule sliding. In addition, the experiments reported here do not eliminate the possibility that the outer arms are also targets of cAMP-dependent regulation. Based on a comparison of the PKI-induced changes in microtubule sliding velocity in p.fl4 or pfl7 axonemes withpf14pf28 axonemes, it is clear that the outer arms contribute to the magnitude of the PKI-induced increase. However, it is not known whether outer arm activity is affected directly by phosphorylation (e.g., Hamasaki et al., 1991; King and Witman, 1994) or indirectly through interaction with other axonemal components such as the inner arms. In either case, the experiments do indicate that outer arms are not uniquely responsible for regulation of sliding velocity. Thus, one priority is to use Chlamydomonas flagellar mutants to determine the substrates of the axonemal cAPK. The use of PKI and RII to regulate microtubule slid-ing in combination with in vitro reconstitution approaches provides new opportunities to identify regulatory substrates that control dynein-based motility.
